AstraZeneca hits snag in COVID drug development

Low-fiber, high-fat diets adversely impact the gut
15 June 2021
Fears breast cancer progress could stall due to COVID-19 backlog
15 June 2021

AstraZeneca hits snag in COVID drug development

Pharmaceutical giant AstraZeneca on Tuesday revealed it had hit a setback in trials of a treatment for COVID-19 symptoms.

Comments are closed.